Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 10—October 2023
Synopsis

Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022

Jennifer Lee, Subin Sunny, Elizabeth Nazarian, Mary Fornek, Marie Abdallah, Briana Episcopia, Marie-Claire Rowlinson, and John QualeComments to Author 
Author affiliations: New York City Health and Hospitals/Kings County, New York, New York, USA (J. Lee, S. Sunny, M. Abdallah, B. Episcopia, J. Quale); New York City Health and Hospitals/Central Office, New York (M. Fornek); Wadsworth Center, New York State Department of Health, Albany, New York, USA (E. Nazarian, M.-C. Rowlinson)

Main Article

Figure 2

Number of proven and presumptive serine and metallo-β-lactamases identified from carbapenem-resistant Klebsiella pneumoniae, New York, New York, USA, January 2016–June 2022.

Figure 2. Number of proven and presumptive serine and metallo-β-lactamases identified from carbapenem-resistant Klebsiella pneumoniae, New York, New York, USA, January 2016–June 2022.

Main Article

Page created: August 11, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external